Park Avenue Securities LLC Acquires 10,085 Shares of SPDR S&P Pharmaceuticals ETF $XPH

Park Avenue Securities LLC bought a new stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 10,085 shares of the company’s stock, valued at approximately $656,000. Park Avenue Securities LLC owned 0.14% of SPDR S&P Pharmaceuticals ETF at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in XPH. Bank of America Corp DE boosted its position in SPDR S&P Pharmaceuticals ETF by 128.0% during the 1st quarter. Bank of America Corp DE now owns 811,939 shares of the company’s stock worth $43,918,000 after purchasing an additional 455,802 shares during the period. Parkway Wealth Management Group LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the third quarter worth about $24,754,000. Envestnet Portfolio Solutions Inc. boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 5.3% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 180,521 shares of the company’s stock worth $11,963,000 after buying an additional 9,042 shares during the period. First Citizens Bank & Trust Co. purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter worth about $11,083,000. Finally, Integrated Wealth Concepts LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the second quarter worth about $3,350,000.

SPDR S&P Pharmaceuticals ETF Stock Performance

XPH stock opened at $65.36 on Thursday. SPDR S&P Pharmaceuticals ETF has a 1 year low of $47.60 and a 1 year high of $74.35. The firm has a market cap of $454.25 million, a P/E ratio of 14.28 and a beta of 0.62. The stock has a 50-day simple moving average of $66.10 and a 200-day simple moving average of $61.84.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.